Letrozole better than tamoxifen in postmenopausal women

被引：6
|
作者：
Fricker, J
机构：
来源：
LANCET ONCOLOGY | 2005年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(05)01758-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [41] Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer
    Dixon, J. Michael
    Renshaw, Lorna
    Young, Oliver
    Murray, Juliette
    Macaskill, E. Jane
    McHugh, Mary
    Folkerd, Elizabeth
    Cameron, David A.
    A'Hern, Roger P.
    Dowsett, Mitch
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1671 - 1676
  • [42] Coronary endothelial function is better in healthy premenopausal women than in healthy older postmenopausal women and men
    Mathews, Lena
    Iantorno, Micaela
    Schar, Michael
    Bonanno, Gabriele
    Gerstenblith, Gary
    Weiss, Robert G.
    Hays, Allison G.
    [J]. PLOS ONE, 2017, 12 (10):
  • [43] Is fulvestrant more effective than tamoxifen for treating ER-positive breast cancer in postmenopausal women?
    Vinod Raina
    [J]. Nature Clinical Practice Oncology, 2004, 1 : 20 - 21
  • [44] Is fulvestrant more effective than tamoxifen for treating ER-positive breast cancer in postmenopausal women?
    Raina, Vinod
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01): : 20 - 21
  • [45] Effect of letrozole on the lipid profile in postmenopausal women with breast cancer
    Elisaf, MS
    Bairaktari, ET
    Nicolaides, C
    Kakaidi, B
    Tzallas, CS
    Katsaraki, A
    Pavlidis, NA
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) : 1510 - 1513
  • [46] Letrozole - A review of its use in postmenopausal women with breast cancer
    Simpson, D
    Curran, MP
    Perry, CM
    [J]. DRUGS, 2004, 64 (11) : 1213 - 1230
  • [47] Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
    Koeberle, Dieter
    Thuerlimann, Beat
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (01) : 5 - 10
  • [48] Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective
    Karnon, Jonathan
    Delea, Thomas
    Barghout, Vicki
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (02): : 171 - 183
  • [49] Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study
    Kishor M. Wasan
    Paul E. Goss
    P. Haydn Pritchard
    Lois Shepherd
    Dongsheng Tu
    James N. Ingle
    [J]. Breast Cancer Research and Treatment, 2012, 136 : 769 - 776
  • [50] Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
    Gil J.M.
    Rubio-Terrés C.
    del Castillo-Saiz A.
    González P.
    Canorea F.
    [J]. Clinical and Translational Oncology, 2006, 8 (5) : 339 - 348
12345